Stocks:
5,168
ETFs:
2,288
Exchanges:
11
Market Cap:
$63.92T
24h Vol:
$4.36B
Dominance:
MSFT:4.92%
Stocklytics Platform
Instrument logo  SERA
Sera Prognostics, Inc.
SERA
65 / 100
High Growth
$9.64arrow_drop_down14.31%-$1.61
Key Stats
Open$11.15
Prev. Close$11.25
EPS-1.16
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$317.12M
PE Ratio-
LOWHIGH
Day Range9.40
11.15
52 Week Range1.52
11.32
Ratios
P/B Ratio5.20
Revenue-
Operating M. %-21,580.49%
Earnings$0.00
Earnings Growth %17.98%
EBITDA Margin %-
ROE %-42.86%
EPS-1.16
Fundamentals
RPS$0.01
Gross Profit-
EBITDA-$38.92M
Total Debt$1.85M
P/S Ratio1,192.1x
Enterprise to EBITDA-9.00
Profit Margin31.37%
ROA-23.51%
Debt/Equity Ratio0.03%
Payout Ratio-
Industry average yield2.97%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

SERAarrow_drop_down14.31%
US Healthcare Sectorarrow_drop_down0.69%
US Marketarrow_drop_down1.11%
warning
SERA / Market
SERA lose to the US Market which returned -1.11% over the last twenty four hours.
warning
SERA / Healthcare Sector
SERA lose to the US Healthcare sector which returned -0.69% over the last twenty four hours.

Sera Prognostics, Inc. (SERA) Statistics

Sera Prognostics, Inc. (SERA) is a company that specializes in developing innovative diagnostic tests for predicting and managing pregnancy complications. The company's stock statistics reflect its performance in the market. As of the latest available data, SERA has a market valuation of $X, with a stock price of $X per share. These valuation metrics demonstrate the investors' perception of the company's potential and its financial standing.

From a fundamental perspective, SERA has shown promising indicators. Its revenue per share stands at $X, indicating the amount of revenue generated per outstanding share. This metric illustrates the company's ability to generate income and grow its business. Additionally, SERA has a healthy profit margin, which measures the percentage of revenue that translates into profits. A higher profit margin suggests efficient operations and strong financial performance.

add Sera Prognostics, Inc. to watchlist

Keep an eye on Sera Prognostics, Inc.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
How has Sera Prognostics, Inc. (SERA) stock's performance compared to its sector and the market over the past year?

Over the past year, Sera Prognostics, Inc. (SERA) has experienced a price change of 169.27%. Compared to the Healthcare sector, which saw a change of 25.13%, Sera Prognostics, Inc. has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 28.69%, it has fallen short of the market average. This comparison highlights Sera Prognostics, Inc.'s performance relative to both its sector and the overall market over the last year.

help
What is the PE ratio of Sera Prognostics, Inc. (SERA) stock?

The PE ratio for Sera Prognostics, Inc. (SERA) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.

help
What is the EPS of Sera Prognostics, Inc. (SERA) stock?

The Earnings Per Share (EPS) for Sera Prognostics, Inc. (SERA), calculated on a diluted basis, is -$1.16. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

help
What is the operating margin of Sera Prognostics, Inc. (SERA) stock?

The operating margin for Sera Prognostics, Inc. (SERA) is -21.58K%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

help
What is the EBITDA of Sera Prognostics, Inc. (SERA) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Sera Prognostics, Inc. (SERA) is -$38.92M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

help
How much debt does Sera Prognostics, Inc. (SERA) have?

Sera Prognostics, Inc. (SERA) has a total debt of $1.86M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$2.02M.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.